Journal of Clinical and Cellular Immunology : Citations & Metrics Report
Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 31 | 30 | 59 | 28 | 11 | 35 | 56 | 95 | 105 | 101 | 105 | 64 | 15 | 3 |
Research, Review articles and Editorials |
2 | 13 | 8 | 23 | 18 | 8 | 25 | 35 | 54 | 86 | 79 | 35 | 23 | 14 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 18 | 22 | 22 | 10 | 3 | 10 | 21 | 39 | 6 | 9 | 7 | 1 | 1 | 0 |
Conference proceedings |
0 | 16 | 15 | 6 | 0 | 98 | 178 | 206 | 171 | 160 | 195 | 156 | 74 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
653 | 826 | 931 | 1079 | 1018 | 971 | 871 | 851 | 753 | 550 | 276 | 145 | 43 | 40 | 0 |
| Journal total citations count | 8361 |
| Journal impact factor | 24.12 |
| Journal 5 years impact factor | 31.14 |
| Journal cite score | 30.45 |
| Journal h-index | 42 |
| Journal h-index since 2019 | 32 |
Important citations (1511)
Klareskog l, amara k, malmström v (2014) adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis. current opinion in rheumatology 26:72-79. |
|
Hohmann c, milles b, schinke m, schroeter m, ulzheimer j, et al (2014) categorization of multiple sclerosis relapse subtypes by b cell profiling in the blood. acta neuropathologica communications 2:138. |
|
Graham ld (2016) treatment methods for rheumatoid arthritis. united states patent us 9,387,246. |
|
Jarouliya u, keservani rk. genomics and proteomic approach in the treatment of various human diseases: applications of genomics and proteomics. recent advances in drug delivery technology. 2016 aug 24:97. |
|
Longbrake ee, cross ah (2016) effect of multiple sclerosis disease-modifying therapies on b cells and humoral immunity. jama neurology 73:219-25. |
|
craddock j, markovic-plese s (2015) immunomodulatory therapies for relapsing-remitting multiple sclerosis: monoclonal antibodies, currently approved and in testing. expert review of clinical pharmacology 8:283-96. |
|
Hayder m, varilh m, turrin co, saoudi a, caminade am, et al.(2015) phosphorus-based dendrimer abp treats neuroinflammation by promoting il-10-producing cd4+ t cells. biomacromolecules 16:3425-33. |
|
Bridel c, lalive ph (2014) update on multiple sclerosis treatments. swiss med wkly 144:w14012. |
|
Mastorodemos v, ioannou m, verginis p (2014). cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications. neuroimmunomodulation 22:181-95. |
|
Wiseman ac. immunosuppressive medications (2015) clinical journal of the american society of nephrology 13:cjn-08570814. |
|
Kuerten s, pommerschein g, barth sk, hohmann c, milles b, s et al.(2014) identification of a b cell-dependent subpopulation of multiple sclerosis by measurements of brain-reactive b cells in the blood. clinical immunology 152:20-4. |
|
vidal-jordana a, sastre-garriga j, rovira a, montalban x (2015). treating relapsing–remitting multiple sclerosis: therapy effects on brain atrophy. journal of neurology 262:2617-26. |
|
Premnath p, ramesh kb, niranjan v, mallikarjunaswamy bp, puttaiah et (2015) a review on biomarkers for prognosis and diagnosis of rheumatic arthritis. american international journal of contemporary scientific research 2: 78-83. |
|
Cole jt. the synthesis and characterization of multifunctional nanoparticles of elastin-like polypeptides for theranostic applications (doctoral dissertation, cleveland state university). |
|
Ally mm, hodkinson b, meyer pw, musenge e, tintinger gr, et al. (2015) circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. bmc musculoskeletal disorders 16: 130. |
|
Cole jt, holland nb (2015) multifunctional nanoparticles for use in theranostic applications. drug delivery and translational research 5: 295-309. |
|
Shigemori s, ihara m, sato t, yamamoto y, nigar s, et al. (2017) secretion of an immunoreactive single-chain variable fragment antibody against mouse interleukin 6 by lactococcus lactis. applied microbiology and biotechnology 101: 341-349. |
|
Malemud cj. take a look at the recent articles. |
|
Malemud cj. vaccine development for rheumatoid arthritis. |
|
Malemud cj, blumenthal de. name of journal: world journal of orthopedics esps manuscript no: 8914 columns: topic highlight. |
|